|
|
Neurodegenerative Disease Market Research Reports
| Dealmaking and Industry Outlook: Neurological Disease |
|
| Table of Contents Published: 2009/11 Published by: Decision Resources, Inc. |
| The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may soon be superseded by new approaches. ... |
| Alzheimer disease - new drugs, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| Alzheimer' s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechan ... |
| Neuroprotection - Drugs, Markets and Companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues ... |
| Immunotherapies and Vaccines for Nontraditional Indications |
|
| Table of Contents Published: 2009/10 Published by: Insight Pharma Reports |
| This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ... |
| World Neurodegenerative Diseases Market 2009-2024 |
|
| Table of Contents Published: 2009/09 Published by: Visiongain |
| Rising neurodegenerative disease prevalence and expanding patent populations - where are the best opportunities and how can you unlock these? Our new report - World Neurodegenerative Diseases Market 2009-2024 - explains. ... |
| Chinese Markets for Central Nervous System Disorder Drugs |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, indu ... |
| The Pricing and Reimbursement Environment for Neurology Drugs |
|
| Table of Contents Published: 2009/08 Published by: Decision Resources, Inc. |
| Neurological disorders will impose a growing social and fi nancial burden on the major pharmaceutical markets as the elderly population in these countries increases steadily. Governments and other payers recognize the pressing need to tackle these disease ... |
| Neurological Disease: Early-Stage R&D and Dealmaking |
|
| Table of Contents Published: 2009/08 Published by: Decision Resources, Inc. |
| How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology drug market? Although brimming with potential, neurology drug development is also rife with unique challenges that many companies and agents have been unable t ... |
| The Neurology Pipeline: A Strategic Review |
|
| Table of Contents Published: 2009/08 Published by: Decision Resources, Inc. |
| Mega-blockbuster status would be quick and sure for any safe, effective agent that prevents the death and damage of neurons associated with neurodegenerative diseases. The potential of such a neuroprotectant is one of the motivations for the 188 companies ... |
| Levodopa (CAS 59-92-7) Market Report 2009 |
|
| Table of Contents Published: 2009/06 Published by: Merchant Research & Consulting LTD. |
| The study 'Levodopa (CAS 59-92-7) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ... |
| Fibromyalgia Market Forecast |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than ... |
| Brands & Strategies: Alzheimer's Disease |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| In 2007, the Alzheimer' s disease (AD) market, valued at more than $3 billion in the United States, Europe, and Japan, was led by sales of Eisai/Pfizer' s Aricept. The growth of all the currently available agents will decline by the end of our forecast, a ... |
| Epilepsy - Therapy Area Pipeline Report |
|
| Table of Contents Published: 2009/05 Published by: Life Science Analytics |
| Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overv ... |
| Alzheimer's Disease: Markets, Pipeline and Opportunities 2009 |
|
| Table of Contents Published: 2009/04 Published by: BioPharm Reports (Technology and Markets Ltd) |
| Today' s armoury of approved drugs for the treatment of Alzheimer' s Disease (AD) largely depends on just five therapeutic agents. In 2007, three of these agents represented 88% of global sales, in a market that this report estimates exceeded $6 billion i ... |
| Chinese Markets for Alzheimer Disease Drugs |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developme ... |
| The Global Multiple Sclerosis Market 2009-2024 |
|
| Table of Contents Published: 2009/03 Published by: Visiongain |
| The multiple sclerosis (MS) market has total global revenues of over $6bn in 2008. Those revenues will exceed $9bn during the second half of next decade, our new study shows. The World Health Organization estimates that over 2.5 million people suffer from ... |
| Global Alzheimer Drugs Market: An Analysis |
|
| Table of Contents Published: 2009/03 Published by: Koncept Analytics |
| This report analyzes Alzheimer' s disease treatment and diagnosis market and discusses major drugs being used for the treatment of AD in United States, Japan and China. It analyses major growth drivers and opportunities present in the market. The report a ... |
| US Markets for Neurostimulation Devices 2009 |
|
| Table of Contents Published: 2009/02 Published by: Millennium Research Group |
| The US market for neurostimulation devices, which includes spinal cord, deep brain, sacral nerve, vagus nerve, and gastric stimulation devices was valued at over $1 billion in 2008. ... |
| Neurodegenerative Market Forecast to 2013 |
|
| Table of Contents Published: 2009/02 Published by: Cutting Edge Information |
| In one convenient, easy-to-access format, Neurodegenerative Market Forecast to 2013 provides a compelling, full picture of the Alzheimer' s, Multiple Sclerosis and Parkinson' s markets. ... |
| Alzheimer's Disease Biomarkers, 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AŔ and tau related markers, a substantial number of other mol ... |
| Sleep Disorders - US - November 2008 |
|
| Table of Contents Published: 2008/11 Published by: Mintel International Group Ltd, |
| The U.S. Sleep Aid market has doubled between 2002 and 2007. OTC and homeopathic segments, which are considerably smaller, are likely to continue growing, fueled by fears surrounding side effects and dependencies that may result from prescription solution ... |
| US Neuropathic Pain 2008, 4th Edition |
|
| Table of Contents Published: 2008/09 Published by: WWMR, Inc. |
| Neuropathic pain (NP) can have chronic, debilitating impact on the lives of patients with a variety of conditions, including low back pain, diabetes, herpes, trigeminal neuralgia, HIV/AIDS, neuropathic cancer pain and fibromyalgia. Many patients and their ... |
|
| Africa and Middle East Media Forecast |
|
| Published by: Pyramid Research, Inc. |
| The following list of definitions has been developed by Pyramid Research to help our clients better understand the data and market analysis presented in our services and reports. It represents an ongoing process in which we continually assess and reevalua ... |
|
| CNS Drug News |
|
| Issues / Year: 22 Published by: Espicom Business Intelligence |
| "An exciting business intelligence service designed to keep you in touch with the latest developments in the central nervous system drug market ... |
| Neuro Drug Focus (NDF) |
|
| Issues / Year: 12 Published by: Espicom Business Intelligence |
| Neuro Drug Focus (NDF) is a new business news service that will keep you fully updated with the latest developments in neurodegenerative product registration, agreements and clinical trials. ... |
|
|
|
View Cart
